CompletedPhase 2

Memantine Treatment of Compulsive Buying

United States10 participantsStarted 2008-12-01

Plain-language summary

This is an 8-week, open-labe study of memantine in the treatment of compulsive buying.

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. men and women age 18-65
✓. current CB using the clinician-administered Structured Clinical Interview for Compulsive buying (SCI-CB)
✓. buying behavior within 2 weeks prior to enrollment

✕. infrequent buying (i.e. less than one time per week) that does not meet proposed criteria for CB
✕. unstable medical illness or clinically significant abnormalities on laboratory tests or physical examination at screen
✕. history of seizures
✕. myocardial infarction within 6 months
✕. current pregnancy or lactation, or inadequate contraception in women of childbearing potential
✕. a need for medication other than memantine with possible psychotropic effects or unfavorable interactions;
✕. clinically significant suicidality;
✕. current Axis I disorder determined by the SCID and SCID-compatible modules for impulse control disorders, except for nicotine dependence

Yale Brown Obsessive Compulsive Scale Modified for CB (CB-YBOCS)

Timeframe: from study start to study end (8-weeks) and is Investigator rated

NCT IDNCT00830375

SponsorUniversity of Minnesota

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-08-01

Results submitted2012-03-01